Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - adrenaline (epinephrine), quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 1.819 mg (equivalent: adrenaline (epinephrine), qty 1 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - adrenaline aguettant 1:10,000 is used as an adjunct in the management of cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 17 july 2003 : lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Kenya - English - Pharmacy and Poisons Board

medisel kenya ltd p.o box 540-01000 thika - adrenaline - injection - adrenaline 1mg/ml - cardiac stimulants excluding cardiac glycosides:

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o box 16633-00620 nairobi-kenya - adrenaline - injection - adrenaline bp 1.0mg/1ml - cardiac stimulants excluding cardiac glycosides:

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875-00100 nairobi - adrenaline - injection - adrenaline 0.1% - cardiac stimulants excluding cardiac glycosides:

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline;  ; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline   lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - the product is indicated for the production of local nerve anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - adrenaline 1 mg/ml - solution for injection - 300 mcg/0.3ml - active: adrenaline 1 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection - for the emergency treatment of serious allergic reactions or anaphylaxis caused by peanuts or other foods, drugs, insect bites or stings and other allergens. anapen® 500, is intended for use in patients with a mean weight of 60 kg, or more or patients at high risk of severe anaphylaxis where the 300 micrograms dose may not be sufficient. anapen® 500 and anapen® 300 should not be used in children with bodyweight below 30 kg.

Ireland - English - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - adrenaline - solution for injection - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; epinephrine

Ireland - English - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - adrenaline - solution for injection - 0.1 milligram(s)/millilitre - adrenergic and dopaminergic agents; epinephrine